<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04328870</url>
  </required_header>
  <id_info>
    <org_study_id>IORG0007981</org_study_id>
    <nct_id>NCT04328870</nct_id>
  </id_info>
  <brief_title>Fluid Absorption in Patients Undergoing Operative Hysteroscopy; Results From a Prospective Controlled Study</brief_title>
  <official_title>The Impact of Spinal Anesthesia and Use of Oxytocin on Fluid Absorption in Patients Undergoing Operative Hysteroscopy; Results From a Prospective Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Jordan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Jordan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine if combining intravenous oxytocin infusion and spinal anesthesia will reduce the
      amount of glycine absorption in patients undergoing operative hysteroscopy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective controlled study in premenopausal patients who had hysteroscopic surgery
      including endometrial resection, endometrial polypectomy, myomectomy resection and uterine
      septal resection. The effect of combined spinal anesthetic with oxytocin infusion on fluid
      deficit was studied.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 20, 2018</start_date>
  <completion_date type="Actual">September 30, 2019</completion_date>
  <primary_completion_date type="Actual">September 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>fluid overload</measure>
    <time_frame>16 months</time_frame>
    <description>Fluid (glycine) excessive absorption into the patient</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">88</enrollment>
  <condition>Fluid Overload</condition>
  <arm_group>
    <arm_group_label>oxytocin and spinal anesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>spinal anesthesia combined with intravenous oxytocin infusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>general anesthsia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>general anesthesia alone</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>oxytocin and spinal anesthesia</intervention_name>
    <description>start oxytocin 10 IU/200 ml saline at the insertion of the spinal anesthesia</description>
    <arm_group_label>oxytocin and spinal anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>General anesthsia</intervention_name>
    <description>General anesthesia alone.</description>
    <arm_group_label>general anesthsia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  premenopausal with no cardiovascular comorbidities

        Exclusion Criteria:

          -  endometrial cancer cases, patients who received pre-operative hormonal preparations,
             previously resected cases and cases done using bipolar diathermy.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>pre-menopausal</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Abdelkarim ALoweidi, consultant</last_name>
    <role>Study Director</role>
    <affiliation>jordan university</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Jordan</name>
      <address>
        <city>Amman</city>
        <zip>11942</zip>
        <country>Jordan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Jordan</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 25, 2020</study_first_submitted>
  <study_first_submitted_qc>March 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 31, 2020</study_first_posted>
  <last_update_submitted>March 30, 2020</last_update_submitted>
  <last_update_submitted_qc>March 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Jordan</investigator_affiliation>
    <investigator_full_name>Naser Al-Husban</investigator_full_name>
    <investigator_title>Assistant Professor and Consultant</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxytocin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>on reasonable request</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

